Marlene Debel - Aug 19, 2022 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Stephen W. Gauster, Authorized Signer
Stock symbol
MET
Transactions as of
Aug 19, 2022
Transactions value $
-$102,726
Form type
4
Date filed
8/23/2022, 05:20 PM
Previous filing
Mar 3, 2022
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Options Exercise $172K +5.51K +10.24% $31.15 59.4K Aug 19, 2022 Direct
transaction MET Common Stock Sale -$274K -4.06K -6.84% $67.60 55.3K Aug 19, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Options Exercise $0 -5.51K -100% $0.00* 0 Aug 19, 2022 Common Stock 5.51K $31.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 19, 2022 and related tax obligations and fees.
F2 The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016.